Results 131 to 140 of about 31,972 (221)

Spinal cord transection repair occurs when Nestin+ cells differentiate into neurons within a taxol-collagen-enhanced microenvironment in mice. [PDF]

Neuroprotection
Fan C, Jiang H, Yan J, Jin L, Fu G, Xue W, Zhang L.   +6 more
europepmc   +1 more source

Microtubules in the axon are GDP bound but adopt a stable GTP-like expanded state. [PDF]

Nat Struct Mol Biol
Zehr EA, Sun S, Sarbanes SL, Roll-Mecak A.   +3 more
europepmc   +1 more source

Measuring Taxol production [PDF]

Nature Biotechnology, 1996
openaire   +2 more sources

Rapid <i>in vivo</i> release of paclitaxel from polymeric micelles. [PDF]

Acta Pharm Sin B
He H, Qi J, Lu Y, Wu W.
europepmc   +1 more source

DUSP12 promotes cell cycle progression and protects cells from ZNF622 mediated apoptosis. [PDF]

Cell Death Dis
Abdusamad M, Guo X, Ramirez I, Velasquez EF, Cohn W, Gholkar AA, Ashley IA, Delgado Y, Bouhaddou M, Whitelegge JP, Damoiseaux R, Torres JZ.   +11 more
europepmc   +1 more source

Design and Pictet-Spengler enabled synthesis of carboxamide-substituted imidazo[1,2-<i>a</i>]quinoxalines as dual EGFR and tubulin targeting anticancer agents. [PDF]

J Enzyme Inhib Med Chem
Chatterjee J, Joshi G, Jha V, Bhujbal SM, Rathour S, Majumdar S, Wahajuddin M, Bharatam PV, Kumar R.   +8 more
europepmc   +1 more source

A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial. [PDF]

Integr Cancer Ther
Hankins J, Bussell M, Gharibvand L, Jeon WJ, Castillo DR, D'Errico E, Nagaraj G.   +6 more
europepmc   +1 more source

Drug Delivery System for the Anticancer Drug Paclitaxel Using Lipocalin-Type Prostaglandin D Synthase Conjugated to a Tumor-Targeting Peptide. [PDF]

ACS Omega
Furuta K, Nakatsuji M, Yoshida H, Okubo R, Nishide K, Yamamura T, Inui T.   +6 more
europepmc   +1 more source

Accessibility of the unstructured α-tubulin C-terminal tail is controlled by microtubule lattice conformation. [PDF]

Elife
Hotta T, Pimm ML, Thomas EC, Yue Y, DeLear P, Blasius L, Cianfrocco MA, DeSantis ME, Horiuchi R, Higaki T, Sept D, Ohi R, Verhey KJ.   +12 more
europepmc   +1 more source

NTRK2 promotes malignant progression and paclitaxel resistance of lung adenocarcinoma through targeting MYC/ABCF1 axis. [PDF]

Transl Oncol
Cui R, Wang Y, Yao Y, Ren X, Zhang Y, Li D, Hou P, Ji M, Qu Y.   +8 more
europepmc   +1 more source